SYBILLE ZIESKE: Open Payments
NPI 1336764638 · LAFAYETTE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 7 payments from 4 companies in 2025. Trend: 2023 $82 · 2024 $0 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $187 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $22 |
Products named: ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, INGREZZA, VIVITROL.
Industry payments across CO — which companies pay providers there.
